These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6103910

  • 1. Effect of the 5-hydroperoxide of eicosatetraenoic acid and inhibitors of the lipoxygenase pathway on the formation of slow reacting substance by rat basophilic leukemia cells; direct evidence that slow reacting substance is a product of the lipoxygenase pathway.
    Falkenhein SF, MacDonald H, Huber MM, Koch D, Parker CW.
    J Immunol; 1980 Jul; 125(1):163-8. PubMed ID: 6103910
    [Abstract] [Full Text] [Related]

  • 2. Slow reacting substance (SRS) from ionophore A23187-stimulated peritoneal mast cells of the normal rat. II. Evidence for a precursor role of arachidonic acid and further purification.
    Yecies LD, Johnson SM, Wedner HJ, Parker CW.
    J Immunol; 1979 May; 122(5):2090-5. PubMed ID: 376731
    [Abstract] [Full Text] [Related]

  • 3. Slow reacting substance (SRS) from ionophore A23187-stimulated human leukemic basophils. I. Evidence for a precursor role of arachidonic acid and initial purification.
    Yecies LD, Wedner HJ, Parker CW.
    J Immunol; 1979 Dec; 123(6):2814-6. PubMed ID: 41019
    [Abstract] [Full Text] [Related]

  • 4. Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells.
    Jakschik BA, Falkenhein S, Parker CW.
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4577-81. PubMed ID: 22078
    [Abstract] [Full Text] [Related]

  • 5. Incorporation of radiolabel from [1-14C]5-hydroperoxy-eicosatetraenoic acid into slow reacting substance.
    Parker CW, Koch D, Huber MM, Falkenhein SF.
    Biochem Biophys Res Commun; 1980 Jun 30; 94(4):1037-43. PubMed ID: 6104961
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Leukotriene D: a slow reacting substance from rat basophilic leukemia cells.
    Orning L, Hammarström S, Samuelsson B.
    Proc Natl Acad Sci U S A; 1980 Apr 30; 77(4):2014-7. PubMed ID: 6103542
    [Abstract] [Full Text] [Related]

  • 8. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells.
    Razin E, Romeo LC, Krilis S, Liu FT, Lewis RA, Corey EJ, Austen KF.
    J Immunol; 1984 Aug 30; 133(2):938-45. PubMed ID: 6330206
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The occurrence of a lipoxygenase pathway in reticulocytes of various species.
    Kroschwald P, Kroschwald A, Wiesner R, Schewe T, Kühn H.
    Biomed Biochim Acta; 1986 Aug 30; 45(10):1237-47. PubMed ID: 3105527
    [Abstract] [Full Text] [Related]

  • 12. Enzymatic assembly of slow reacting substance.
    Jakschik BA, Lee LH.
    Nature; 1980 Sep 04; 287(5777):51-2. PubMed ID: 6106162
    [Abstract] [Full Text] [Related]

  • 13. Release of slow reacting substance (SRS) from rat basophilic leukemia (RBL-1) cells.
    Jakschik BA, Kulczycki A, MacDonald HH, Parker CW.
    J Immunol; 1977 Aug 04; 119(2):618-22. PubMed ID: 328779
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the two major species of slow reacting substance from rat basophilic leukemia cells as glutathionyl thioethers of eicosatetraenoic acids oxygenated at the 5 position. Evidence that peroxy groups are present and important for spasmogenic activity.
    Parker CW, Huber MM, Hoffman MK, Falkenhein SF.
    Prostaglandins; 1979 Nov 04; 18(5):673-86. PubMed ID: 44377
    [Abstract] [Full Text] [Related]

  • 15. Competitive inhibition of the 5-lipoxygenase-catalysed linoleate oxidation by arachidonic and 5-hydroperoxy-eicosatetraenoic acids.
    Mirzoeva OK, Sud'ina GF, Pushkareva MA, Varfolomeev SD.
    FEBS Lett; 1995 Dec 27; 377(3):306-8. PubMed ID: 8549743
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of slow reacting substance-like activity in rabbit conjunctiva and anterior uvea.
    Kulkarni PS, Srinivason BD.
    Invest Ophthalmol Vis Sci; 1983 Aug 27; 24(8):1079-85. PubMed ID: 6135672
    [Abstract] [Full Text] [Related]

  • 17. C5a-induced tracheal contraction: effect of an SRS-A antagonist and inhibitors of arachidonate metabolism.
    Regal JF, Pickering RJ.
    J Immunol; 1981 Jan 27; 126(1):313-6. PubMed ID: 7451973
    [Abstract] [Full Text] [Related]

  • 18. Role of arachidonic acid in the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) from sensitized guinea pig lung fragments: evidence that SRS-A is very similar or identical structurally to nonimmunologically induced forms of SRS.
    Watanabe-Kohno S, Parker CW.
    J Immunol; 1980 Aug 27; 125(2):946-55. PubMed ID: 6104681
    [No Abstract] [Full Text] [Related]

  • 19. Arachidonic acid metabolites as intracellular modulators of the G protein-gated cardiac K+ channel.
    Kurachi Y, Ito H, Sugimoto T, Shimizu T, Miki I, Ui M.
    Nature; 1989 Feb 09; 337(6207):555-7. PubMed ID: 2492639
    [Abstract] [Full Text] [Related]

  • 20. Effects of 12-hydroxy- and 12-hydroperoxy-5,8,10,14-eicosatetraenoic acids on the synthesis of 5-hydroxy-6,8,11,14-eicosatetraenoic acid and leukotriene B4 in human blood leukocytes.
    Maclouf J, Fruteau de Laclos B, Borgeat P.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Feb 09; 11():159-62. PubMed ID: 6221520
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.